Post-earnings recap
Reported
Mon, Aug 5, 2024
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Castle Biosciences reported a strong earnings surprise with an EPS of $0.31, significantly above expectations. However, the stock reacted negatively, declining by 1.93%. The lack of revenue details and management commentary may have contributed to investor uncertainty.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.31 | N/A | +293.75% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based solely on numerical results.